HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

acipimox

TERMINATED · PHASE2 · Acute Heart Failure

due to slow recruitment

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.